JCI - Citations to Inhibition of immune functions by antiviral drugs.

Citations to this article

Inhibition of immune functions by antiviral drugs.

W Heagy, … , P A Lopez, R W Finberg

W Heagy, … , P A Lopez, R W Finberg

Published June 1, 1991
Citation Information: J Clin Invest. 1991;87(6):1916-1924. https://doi.org/10.1172/JCI115217.

View: Text | PDF

Research Article

Total citations by year

Year:	2024	2023	2022	2021	2020	2019	2017	2016	2014	2012	2011	2010	2009	2008	2007	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	Total
Citations:	3	1	2	3	3	2	1	2	5	4	1	4	1	5	9	3	3	4	6	5	3	4	6	2	6	3	3	3	6	103

Citation information

Citations to this article (103)

Title and authors	Publication	Year
Cytomegalovirus immunity with preemptive vs. prophylactic antiviral therapy after donor seropositive, recipient seronegative liver transplant Danniel Zamora, Sayan Dasgupta, Terry Stevens-Ayers, Bradley Edmison, Drew Winston, Raymund Razonable, Aneesh Mehta, G. Marshall Lyon, Michael Boeckh, Nina Singh, David Koelle, Ajit Limaye	JCI Insight	2024
The hnRNP A2B1 is important for the replication of SFTSV and other RNA viruses Zhang X, Yan LN, Liu BY, Zhou CM, Yu XJ	Microbiology Spectrum	2024
Effects of combined immunosuppressant and hepatitis B virus antiviral use on COVID-19 vaccination in recipients of living donor liver transplantation Lee R, Choi J, Lee E, Lee J, Kim J, Kang S, An HI, Kim SH, Kim SM, Jwa EK, Park GC, Namgoong JM, Song GW, Yoon YI, Tak E, Lee SG	PeerJ	2024
Herpes Zoster: A Case Report of a Rare Ramification Leading to Secondary Infection. Warrier S A, Ganesh S, Harikrishnan T, Balaji B, Venugopal DC, S S	Cureus	2023
A Review with Updated Perspectives on the Antiviral Potentials of Traditional Medicinal Plants and Their Prospects in Antiviral Therapy. Saifulazmi NF, Rohani ER, Harun S, Bunawan H, Hamezah HS, Nor Muhammad NA, Azizan KA, Ahmed QU, Fakurazi S, Mediani A, Sarian MN		2022
The establishment of a cytomegalovirus -specific CD8⁺ T-cell threshold by kinetic modeling for the prediction of post-hemopoietic stem cell transplant reactivation. Zhang J, Cao J, Zheng R, Yu M, Lin Z, Wang C, McCluskey J, Yang J, Chen Z, Corbett AJ, Cao P, Mo W, Wang Z	iScience	2022
Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages GD Liatsos	World journal of clinical cases	2021
Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation D Zamora, ER Duke, H Xie, BC Edmison, B Akoto, R Kiener, T Stevens-Ayers, R Wagner, M Mielcarek, WM Leisenring, KR Jerome, JT Schiffer, G Finak, SC Rosa, M Boeckh	Blood	2021
A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients PR Selby, S Shakib, SL Peake, MS Warner, D Yeung, U Hahn, JA Roberts	Clinical Pharmacokinetics	2021
Cytomegalovirus replication is associated with enrichment of distinct γδ T cell subsets following lung transplantation: A novel therapeutic approach? S Stankovic, MS Davey, EM Shaw, A von Borstel, Y Cristiano, BJ Levvey, J Rossjohn, GP Westall, GI Snell, AG Brooks, LC Sullivan	The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation	2020
Immune disorders in the recuperation period. Justification of the Immunomax use OA Gizinger		2020
Cytomegalovirus after kidney transplantation in 2020: moving towards personalized prevention R Hellemans, D Abramowicz	Nephrology Dialysis Transplantation	2020
Effects of dietary supplementation with S. platensis and probiotics on the growth performance, immune response and the fecal Lactobacillus spp. and E. coli contents of weaned piglets L Zhang, P Jin, S Qin, J Liu, Z Yang, H Zhao, Q Sheng	Livestock Science	2019
Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy T Reischig, M Kacer, O Hes, J Machova, J Nemcova, D Lysak, P Jindra, K Pivovarcikova, S Kormunda, M Bouda	American Journal of Transplantation	2019
Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus XY Pei, XY Zhao, YJ Chang, J Liu, LP Xu, Y Wang, XH Zhang, W Han, YH Chen, XJ Huang	The Journal of Infectious Diseases	2017
Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro: A Tschan-Plessl, M Stern, L Schmied, C Retière, HH Hirsch, C Garzoni, C Delden, K Boggian, NJ Mueller, C Berger, J Villard, O Manuel, P Meylan, G Terszowski	Transplantation Direct	2016
In vitro studies of the impact of maribavir on CMV-specific cellular immune responses D Stachel, T Stevens-Ayers, M Boeckh	Journal of Clinical Virology	2016
Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients N Kamar, J Izopet, S Tripon, M Bismuth, S Hillaire, J Dumortier, S Radenne, A Coilly, V Garrigue, L D'Alteroche, M Buchler, L Couzi, P Lebray, S Dharancy, A Minello, M Hourmant, AM Roque-Afonso, F Abravanel, S Pol, L Rostaing, V Mallet	New England Journal of Medicine	2014
Comparison of the chronic effects of ribavirin and caffeic acid phenethyl ester (CAPE) on pancreatic damage and hepatotoxicity S Motor, H Alp, S Senol, N Pınar, VK Motor, I Kaplan, A Alp, C Gökçe	International journal of clinical and experimental medicine	2014
Randomized Trial of Valganciclovir Versus Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation T Reischig, M Kacer, P Jindra, O Hes, D Lysak, M Bouda	Clinical journal of the American Society of Nephrology : CJASN	2014
Cellular stress marker alteration and inflammatory response in pigs fed with an ochratoxin contaminated diet C Bernardini, E Grilli, JC Duvigneau, A Zannoni, B Tugnoli, F Gentilini, T Bertuzzi, S Spinozzi, C Camborata, ML Bacci, A Piva, M Forni	Research in Veterinary Science	2014
Antiviral Drugs for Influenza and Other Respiratory Virus Infections Aoki FY	Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases	2014
Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1) SG Zarogiannis, JW Noah, A Jurkuvenaite, C Steele, S Matalon, DL Noah	Life Sciences	2012
Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy T Reischig	Expert Review of Anti-infective Therapy	2012
Post-transplant liver biopsy and the immune response: lessons for the clinician S Shetty, DH Adams, SG Hubscher	Expert Review of Clinical Immunology	2012
The Centrosome H Schatten		2012
Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients N Selzner, M Guindi, EL Renner, M Berenguer	Journal of Hepatology	2011
The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey I Koksal, G Yilmaz, F Aksoy, H Aydin, I Yavuz, S Iskender, K Akcay, S Erensoy, R Caylan, K Aydin	Journal of Clinical Virology	2010
Prevention of Cytomegalovirus in Organ Transplant Recipients: Cross Roads Between Antiviral and Antitumor Immunity N Singh	Transplantation	2010
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases VG Fowler, WM Scheld, AS Bayer	Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases	2010
High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection AJ Saleh, FA Mohareb, FA Rabiah, N Chaudhri, FA Sharif, HA Zahrani, SY Mohamed, M Patel, W Rasheed, Z Nurgat, M Bakr, S Ahmed, S Zaidi, A Nassar, K Ibrahim, HA Abdely, M Aljurf	Hematology/Oncology and Stem Cell Therapy	2010
Effect of Duration and Intensity of Ganciclovir Exposure on Lymphoblastoid Cell Toxicity A Janoly-Dumenil, I Rouvet, N Bleyzac, Y Bertrand, G Aulagner, MT Zabot	Antiviral Chemistry & Chemotherapy	2009
Treatment of Crimean-Congo hemorrhagic fever O Ergonul	Antiviral Research	2008
Respiratory viruses other than influenza virus: impact and therapeutic advances WG Nichols, AJ Campbell, M Boeckh	Clinical microbiology reviews	2008
Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: Clinical and histopathological evaluation D Stojkov, I Lavrnja, S Pekovic, S Dacic, I Bjelobaba, M Mostarica-Stojkovic, S Stosic-Grujicic, S Jovanovic, N Nedeljkovic, L Rakic, M Stojiljkovic	Journal of the Neurological Sciences	2008
Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production I Lavrnja, D Stojkov, I Bjelobaba, S Pekovic, S Dacic, N Nedeljkovic, M Mostarica-Stojkovic, S Stosic-Grujicic, L Rakic, M Stojiljkovic	International Immunopharmacology	2008
Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation K Perruccio, F Topini, A Tosti, A Carotti, T Aloisi, F Aversa, MF Martelli, A Velardi	Blood Cells, Molecules, and Diseases	2008
Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors OA Olivero	Environmental and Molecular Mutagenesis	2007
Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation NG Almyroudis, A Jakubowski, D Jaffe, K Sepkowitz, E Pamer, RJ O'Reilly, GA Papanicolaou	Transplant Infectious Disease	2007
Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach AL Zignego, C Ferri, SA Pileri, P Caini, FB Bianchi	Digestive and Liver Disease	2007
African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine L Kuhn, DB Schramm, S Donninger, S Meddows-Taylor, AH Coovadia, GG Sherman, GE Gray, CT Tiemessen	AIDS	2007
Immunomodulatory effects of two HIV protease inhibitors, Saquinavir and Ritonavir, on lymphocytes from healthy seronegative individuals OM Delmonte, G Bertolotto, E Ricotti, PA Tovo	Immunology Letters	2007
Hepatitis C virus-related lymphoproliferative disorders: an overview AL Zignego, C Giannini, C Ferri	World journal of gastroenterology : WJG	2007
Crimean-Congo Hemorrhagic Fever O Ergonul, CA Whitehouse		2007
HIV and the Pathogenesis of AIDS JA Levy		2007
Treatment of Crimean-Congo Hemorrhagic Fever Ergonul O, Mirazimi A, Dimitrov DS		2007
Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C N Kamar, A Boulestin, J Selves, L Esposito, K Sandres-Saune, M St�benet, E Chatelut, D Durand, L Rostaing, J Izopet	Journal of Medical Virology	2005
Combination of Nucleoside Analogues Tiazofurin and Ribavirin Downregulates Experimental Autoimmune Encephalomyelitis I Lavrnja, D Stojkov, S Peković, S Šubašić, M Mostarica-Stojković, S Stošic-Grujičić, N Nedeljković, L Medić-Mijačević, L Rakić, M Stojiljković	Annals of the New York Academy of Sciences	2005
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation K Perruccio, A Tosti, E Burchielli, F Topini, L Ruggeri, A Carotti, M Capanni, E Urbani, A Mancusi, F Aversa, MF Martelli, L Romani, A Velardi	Blood	2005
Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation RT Stravitz, ML Shiffman, AJ Sanyal, VA Luketic, RK Sterling, DM Heuman, A Ashworth, AS Mills, M Contos, AH Cotterell, D Maluf, MP Posner, RA Fisher	Liver Transplantation	2004
Respiratory Viruses and Severe Lower Respiratory Tract Complications in Hospitalized Patients J Garbino, MW Gerbase, W Wunderli, L Kolarova, LP Nicod, T Rochat, L Kaiser	Chest	2004
Pegylating IFNs at His-34 Improves the in Vitro Antiviral Activity Through the JAK/STAT Pathway MJ Grace, D Cutler	Antiviral Chemistry & Chemotherapy	2004
Hepatitis c virus-specific cytolytic t cell responses after antiviral therapy C Morishima, L Musey, M Elizaga, K Gaba, M Allison, RL Carithers, DR Gretch, MJ McElrath	Clinical Immunology	2003
Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology N Kamar, K Sandres-Saune, J Selves, D Ribes, O Cointault, D Durand, J Izopet, L Rostaing	American Journal of Kidney Diseases	2003
Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis N Kamar, L Rostaing, A Boulestin, K Sandres, M Dubois, D Ribes, A Modesto, D Durand, J Izopet	Journal of Medical Virology	2003
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity M Boeckh, W Leisenring, SR Riddell, RA Bowden, ML Huang, D Myerson, T Stevens-Ayers, ME Flowers, T Cunningham, L Corey	Blood	2003
The human 26S proteasome is a target of antiretroviral agents M Piccinini, MT Rinaudo, N Chiapello, E Ricotti, S Baldovino, M Mostert, PA Tovo	AIDS	2002
PHARMACOLOGICAL AND BIOLOGICAL ASPECTS OF BASIC RESEARCH ON NUCLEOSIDE-BASED REVERSE TRANSCRIPTASE INHIBITORS B Macchi, A Mastino	Pharmacological Research	2002
Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV S Francke, CG Orosz, J Hsu, LE Mathes	Antimicrobial agents and chemotherapy	2002
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo A Bergamini, M Cepparulo, F Bolacchi, A Araco, G Tisone, D Ombres, G Rocchi, M Angelico	Clinical & Experimental Immunology	2002
Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infection V Loustaud-Ratti, E Liozon, H Karaaslan, S Alain, F Paraf, YL Meur, F Denis, E Vidal	The American Journal of Medicine	2002
Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants P Ljungman, R de la Camara, N Milpied, L Volin, CA Russell, A Crisp, A Webster	Blood	2002
Vertical HIV-1 Transmission: Importance of Neutralizing Antibody Titer and Specificity V Bongertz, CI Costa, VG Veloso, B Grinsztejn, EC Filho, G Calvet, JH Pilotto, ML Guimarães, MG Morgado	Scandinavian Journal of Immunology	2001
Ribavirin - current status of a broad spectrum antiviral agent NJ Snell	Expert Opinion on Pharmacotherapy	2001
The Benefit of Long-term Interferon Alfa Therapy for Symptomatic Mixed Cryoglobulinemia (Cutaneous Vasculitis/Membranoproliferative Glomerulonephritis) Associated With Chronic Hepatitis C Infection RA Willson	Journal of Clinical Gastroenterology	2001
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection SA Stranford, JC Ong, B Martinez-Marino, M Busch, FM Hecht, J Kahn, JA Levy	Proceedings of the National Academy of Sciences	2001
Antiviral drugs can inhibit lymphocyte apoptosis induced by cytomegalovirus antigens J Briceño, J la Torre-Cisneros, A Alvarez-Kindelan, P Sanchez-Guijo, C Pera	Transplantation Proceedings	2001
Effect of zidovudine on the primary cytolytic T-lymphocyte response and T-cell effector function S Francke, CG Orosz, KA Hayes, LE Mathes	Antimicrobial agents and chemotherapy	2000
Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level SH Fang, LH Hwang, DS Chen, BL Chiang	Journal of Hepatology	2000
Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C M E Cramp, S Rossol, S Chokshi, P Carucci, R Williams, N V Naoumov	Gastroenterology	2000
Treatment of recurrent hepatitis C following liver transplantation T Bizollon, C Ducerf, J Baulieux, C Trepo	Current Gastroenterology Reports	1999
Nitric Oxide Modulates HIV-1 Replication JB Mannick, JS Stamler, E Teng, N Simpson, J Lawrence, J Jordan, RW Finberg	Journal of Acquired Immune Deficiency Syndromes	1999
Hepatitis C virus recurrence after liver transplantation T Bizollon, C Ducerf, C Trepo, D Mutimer	Gut	1999
Toxicology R Neubert, D Neubert	Toxicology	1999
Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients HP Pham, C Feray, D Samuel, M Gigou, D Azoulay, V Paradis, F Ducret, B Charpentier, B Debuire, A Lemoine	Kidney International	1998
Combination therapy of chronic hepatitis C: an important step but not the final goal! H Wedemeyer, WH Caselmann, MP Manns	Journal of Hepatology	1998
Antiviral prophylaxis and treatment in chickenpox MM Ogilvie	Journal of Infection	1998
Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus JH Lee, M Wagner, WK Roth, G Teuber, C Sarrazin, S Zeuzem	Journal of Hepatology	1998
Ribavirin inhibits protein synthesis and cell proliferation induced by mitogenic factors in primary human and rat hepatocytes: Ribavirin Inhibits Protein Synthesis and Cell Proliferation Induced by Mitogenic Factors in Primary Human and Rat Hepatocytes GP Ilyin, S Langouët, M Rissel, JG Delcros, A Guillouzo, C Guguen-Guillouzo	Hepatology	1998
Lack of immunotoxicity of saquinavir (Ro 31-8959) used alone or in double or triple combination with AZT and ddC M Viora, G Di Genova, M G Quaranta, M Boirivant, B Camponeschi	Journal of Clinical Immunology	1998
Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus LF Aleixo, MM Goodenow, JW Sleasman	The Journal of Pediatrics	1997
Interference with cell cycle progression and induction of apoptosis by dideoxynucleoside analogs M Viora, GD Genova, R Rivabene, W Malorni, A Fattorossi	International Journal of Immunopharmacology	1997
Herpetic stromal disease: Response to acyclovir/steroid therapy WJ O'Brien, AP Segundo, J Guy, EM Dorn, JL Taylor	Acta Ophthalmologica Scandinavica	1996
Evidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacy LE Mathes, KA Hayes, G Kociba	Antimicrobial agents and chemotherapy	1996
The Immunomodulatory Effects of Antibiotics: In Vitro and Ex Vivo Investigations of 21 Substances by Means of the Lymphocyte Transformation Test S Schubert, BH Andresen, V Bäahr, L Fischer, R Stamp, G Stricker, JW Wittke, U Ullmann	Zentralblatt für Bakteriologie	1996
Zidovudine and psoriasis RB Stricker, B Goldberg	Journal of the American Academy of Dermatology	1996
In vitro lymphotoxicity and selective t cell immunotoxicity of high doses of acyclovir and its derivatives in mice L Poluektova, K Krzystyniak, R Desjardins, D Flipo, M Fournier	International Journal of Immunopharmacology	1996
A PILOT STUDY OF RIBAVIRIN THERAPY FOR RECURRENT HEPATITIS C VIRUS INFECTION AFTER LIVER TRANSPLANTATION1: MS Cattral, M Krajden, IR Wanless, M Rezig, R Cameron, PD Greig, SW Chung, GA Levy	Transplantation	1996
HIV-1 chemotherapy and drug resistance R Daquila	Clinical and Diagnostic Virology	1995
A pilot, open-labelled, phase II study using oral ribavirin in the treatment of patients with chronic active hepatitis B MJ Tong, SJ Hwang, M Lefkowitz, SD Lee, RL Co, KJ Lo	Clinical and Diagnostic Virology	1995
Evaluation of the Immunotoxicity of Antiretroviral Drugs Using an In Vitro Method for the Induction and Measurement of a Specific Antibody Response in Human Peripheral Blood Lymphocytes AL Luzzati, E Giacomini, L Giordani	Alternatives to laboratory animals : ATLA	1995
Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin MJ Tong, SJ Hwang, M Lefkowitz, SD Lee, RL Co, A Conrad, P Schmid, KJ Lo	Journal of Gastroenterology and Hepatology	1994
9-(2-Phosphonylmethoxyethyl) adenine increases the survival of influenza virus-infected mice by an enhancement of the immune system N Villani, R Caliò, E Balestra, J Balzarini, ED Clercq, E Fabrizi, CF Perno, VD Gobbo	Antiviral Research	1994
Aciclovir: A Reappraisal of its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy AJ Wagstaff, D Faulds, KL Goa	Drugs	1994
Acyclovirl is it an effective virostatic agent for orofacial infections? CL Lavelle	Journal of Oral Pathology and Medicine	1993
Pilot study of ribavirin and interferon-β for chronic hepatitis B S Kakumu, K Yoshioka, T Wakita, T Ishikawa, M Takayanagi, Y Higashi	Hepatology	1993
Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1 A Erice, DL Mayers, DG Strike, KJ Sannerud, FE McCutchan, K Henry, HH Balfour	New England Journal of Medicine	1993
Viruses, chemotherapy and immunity MJ Koziel, BD Walker	Parasitology	1992
Antiviral therapy: current concepts and practices B Bean	Clinical microbiology reviews	1992
A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection JO Kahn, SW Lagakos, DD Richman, A Cross, C Pettinelli, S Liou, M Brown, PA Volberding, CS Crumpacker, G Beall, HS Sacks, TC Merigan, M Beltangady, L Smaldone, R Dolin	New England Journal of Medicine	1992
Psoriasis and human immunodeficiency virus infection ML Obuch, TA Maurer, B Becker, TG Berger	Journal of the American Academy of Dermatology	1992
Topics in Clinical Pharmacology: Ganciclovir S Paul, S Dummer	The American Journal of the Medical Sciences	1992
Didanosine: A Review of its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Potential in Human Immunodeficiency Virus Infection D Faulds, RN Brogden	Drugs	1992

Advertisement